We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

We reveal the 3 investment megatrends that are captured in the top 10 holdings of the Vanguard MSCI Index International Shares ETF (ASX: VGS).

Dr Lotte Knudson, a scientist from Copenhagen, revolutionized research into drugs used by millions to lose weight. She has ...

AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo-Swedish drugmaker's closely watched weight loss pill, AZD5004, showed 5.8% ...

Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...

Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share and revenue of $382.2 million, ...